相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis
Qian Xiang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
Nuthalapati Ramakumari et al.
INDIAN HEART JOURNAL (2018)
Association of genetic variations with pharmacokinetics and lipid-lowering response toatorvastatin in healthy Korean subjects
Hye In Woo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Association between SLCO1B1-521T>C and-388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis
Jiajia Jiang et al.
SPRINGERPLUS (2016)
Pharmacogenomics of statins: understanding susceptibility to adverse effects
Joseph P. Kitzmiller et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2016)
Association between SLCO1B1 521 T> C and 388 A >G Polymorphisms and Statins Effectiveness: A Meta-Analysis
Rong Dai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis
Jia Su et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk A Meta-Analysis of Case-Control Studies
Qingtao Hou et al.
MEDICINE (2015)
Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins
Ye Dou et al.
ANNALS OF LABORATORY MEDICINE (2015)
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
L. B. Ramsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
William J. Canestaro et al.
GENETICS IN MEDICINE (2014)
An assessment by the Statin Liver Safety Task Force: 2014 update
Harold Bays et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population
E. Giannakopoulou et al.
MOLECULAR BIOLOGY REPORTS (2014)
Effect of Statins on Skeletal Muscle Function
Beth A. Parker et al.
CIRCULATION (2013)
The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort
Michel R. Hoenig et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Combination statin-fibrate therapy: safety aspects
R. Franssen et al.
DIABETES OBESITY & METABOLISM (2009)
The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment
M Fiegenbaum et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
分享论文
